Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.mehy.2021.110621 http://scihub22266oqcxt.onion/10.1016/j.mehy.2021.110621 34116360!8176888!34116360     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Med+Hypotheses 2021 ; 152 (ä): 110621 Nephropedia Template TP {{tp|p=34116360|t=2021. Should we screen Eastern Mediterranean COVID-19 patients for inherited thrombophilia?|pdf=|usr=}}{{34116360}} gab.com Text Should we screen Eastern Mediterranean COVID-19 patients for inherited thrombophilia JO: Med Hypotheses http://www.kidney.de/pget.php?&tw=1&pmid=34116360 #FOAvip The inflammatory component of Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) creates a pro-thrombotic state that necessitates a thrombophylactic strategy for hospitalized patients. Such strategies are difficult to be standardized because certain individuals can have pro-thrombotic conditions, such as inherited thrombophilia, which pre-dispose them to an additional coagulative risk. Whether outside the hospital or when admitted, patients with inherited thrombophilia need special anticoagulant and antiplatelet attention. Identifying such patients, especially in susceptible populations like the eastern Mediterranean (EM) region, will aid primary providers in risk stratification for choosing the optimal anticoagulation or antiplatelet plan. Twit Text FOAVip Should we screen Eastern Mediterranean COVID-19 patients for inherited thrombophilia ????Med Hypotheses http://www.kidney.de/pget.php?&tw=1&pmid=34116360 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34116360 #FOAvip English Wikipedia <ref>{{Cite pmid|34116360}}</ref> Should we screen Eastern Mediterranean COVID-19 patients for inherited thrombophilia? #MMPMID34116360 El Hasbani G; Taher AT Med Hypotheses 2021[Jul]; 152 (ä): 110621 PMID34116360show ga The inflammatory component of Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) creates a pro-thrombotic state that necessitates a thrombophylactic strategy for hospitalized patients. Such strategies are difficult to be standardized because certain individuals can have pro-thrombotic conditions, such as inherited thrombophilia, which pre-dispose them to an additional coagulative risk. Whether outside the hospital or when admitted, patients with inherited thrombophilia need special anticoagulant and antiplatelet attention. Identifying such patients, especially in susceptible populations like the eastern Mediterranean (EM) region, will aid primary providers in risk stratification for choosing the optimal anticoagulation or antiplatelet plan. |*COVID-19[MESH] |*Thrombophilia/complications[MESH] |*Thrombosis[MESH] |Anticoagulants/therapeutic use[MESH] |Humans[MESH]Should we screen Eastern Mediterranean COVID-19 patients for inherited(epmc).pdf DeepDyve Pubget Overpricing